Trial Profile
A Randomized, Double-Blind, Vehicle-Controlled, Parallel Arm Study of 552-02 in Subjects With Dry Mouth Associated With Sjogren's Syndrome
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Sep 2018
Price :
$35
*
At a glance
- Drugs 552 02 (Primary)
- Indications Xerostomia
- Focus Therapeutic Use
- Sponsors Parion Sciences
- 13 May 2014 New trial record